✦ LIBER ✦

667 HEPATITIS B VIRUS DNA LEVEL IS A SIGNIFICANT PREDICTIVE FACTOR FOR HEPATITIS B VIRUS REACTIVATION IN INACTIVE HBS ANTIGEN CARRIERS

✍ Scribed by Y.S. Seo; Y.D. Kwon; S. Park; B. Keum; Y.S. Kim; H.J. Yim; Y.T. Jeen; H.J. Chun; C.D. Kim; H.S. Ryu; S.H. Um

Book ID: 117376593
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 65 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60669-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is there a meaningful serum hepatitis B

Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection?

✍ George V. Papatheodoridis; Emanuel K. Manesis; Spilios Manolakopoulos; Ioannis S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

The diagnosis of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B indicating therapeutic intervention currently requires serum hepatitis B virus (HBV) DNA >2,000 IU/mL. We evaluated the severity of liver histology and the presence of histological indication for treatment in patients with H

Lamivudine is effective in suppressing h

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial

✍ C. Lai; C. Ching; A. K. Tung; E. Li; J. Young; A. Hill; B. C. Wong; J. Dent; P. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

Lamivudine is effective in suppressing h

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial

✍ C Lai; C Ching; AK Tung; E Li; J Young; A Hill; BC Wong; J Dent; P Wu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Comparison between quantitative hepatiti

Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B

✍ Pisit Tangkijvanich; Piyawat Komolmit; Varocha Mahachai; Pattaratida Sa-nguanmoo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

425 Lowest serum hepatitis B virus DNA l

425 Lowest serum hepatitis B virus DNA level is predicable factor for viral breakthrough during lamivudine therapy in chronic hepatitis B patients

✍ M. Cho; J. Heo; D.Y. Lyu; B.M. Cho; H.H. Kim; G.H. Kim; D.H. Kang; G.A. Song; U. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

A case-control study for early predictio

A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter

✍ Takahiro Yamaura; Eiji Tanaka; Akihiro Matsumoto; Akinori Rokuhara; Koji Orii; K 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract Factors influencing and predictive of seroconversion from hepatitis B e antigen (HBeAg) to antibody (anti‐HBe) were sought in a case‐control study of 61 patients with chronic hepatitis B who had been observed from 5 years before to 1 year after seroconversion, and 32 patients who did no